Scope Fluidics Spolka Akcyjna (FRA:S84) Gross Margin %: -2,883.33% (As of Mar. 2026)


FRA:S84 Scope Fluidics Spolka Akcyjna FRA:S84
45 GF Score
Price €23.50
GF Value €26.71
! 4 Warning Signs
View Full Analysis

What is Scope Fluidics Spolka Akcyjna Gross Margin %?

Scope Fluidics Spolka Akcyjna FRA:S84 -2.08% 45 Gross Margin % is -2,883.33% as of Mar. 2026. GuruFocus rates FRA:S84 with a GF Score™ of 45/100 and a GF Value™ of €26.71. The stock has 4 warning signs investors should review. Among 194 Medical Diagnostics & Research companies, Scope Fluidics Spolka Akcyjna ranks worse than 100% on this metric.

Gross Margin % is calculated as gross profit divided by its revenue. Scope Fluidics Spolka Akcyjna's Gross Profit for the three months ended in Mar. 2026 was €-0.17 Mil. Scope Fluidics Spolka Akcyjna's Revenue for the three months ended in Mar. 2026 was €0.01 Mil. Therefore, Scope Fluidics Spolka Akcyjna's Gross Margin % for the quarter that ended in Mar. 2026 was -2,883.33%.


The historical rank and industry rank for Scope Fluidics Spolka Akcyjna's Gross Margin % or its related term are showing as below:

FRA:S84' s Gross Margin % Range Over the Past 10 Years
Min: -20100   Med: -583.71   Max: -106.01
Current: -3873.08


During the past 10 years, the highest Gross Margin % of Scope Fluidics Spolka Akcyjna was -106.01%. The lowest was -20100.00%. And the median was -583.71%.

FRA:S84's Gross Margin % is ranked worse than
100% of 194 companies
in the Medical Diagnostics & Research industry
Industry Median: 50.45 vs FRA:S84: -3873.08

Scope Fluidics Spolka Akcyjna had a gross margin of -2,883.33% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Scope Fluidics Spolka Akcyjna was 0.00% per year.


Scope Fluidics Spolka Akcyjna  (FRA:S84) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Scope Fluidics Spolka Akcyjna had a gross margin of -2,883.33% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Scope Fluidics Spolka Akcyjna Gross Margin % Related Terms


Scope Fluidics Spolka Akcyjna Gross Margin % Historical Data

* Premium members only.

The historical data trend for Scope Fluidics Spolka Akcyjna's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scope Fluidics Spolka Akcyjna Gross Margin % Chart

Scope Fluidics Spolka Akcyjna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -115.22 -265.81 -893.33 -3,591.30

Scope Fluidics Spolka Akcyjna Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,700.00 -118.24 -4,900.00 236.03 -2,883.33

FRA:S84 vs TMO, DHR, IDXX: Gross Margin % Comparison

For the Diagnostics & Research subindustry, Scope Fluidics Spolka Akcyjna's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scope Fluidics Spolka Akcyjna Gross Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Scope Fluidics Spolka Akcyjna's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Scope Fluidics Spolka Akcyjna's Gross Margin % falls into.


FRA:S84
45GF Score
Scope Fluidics Spolka Akcyjna FRA:S84
Gross Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scope Fluidics Spolka Akcyjna Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Scope Fluidics Spolka Akcyjna's Gross Margin for the fiscal year that ended in Dec. 2025 is calculated as

Gross Margin % (A: Dec. 2025 )=Gross Profit (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=-0.8 / 0.023
=(Revenue - Cost of Goods Sold) / Revenue
=(0.023 - 0.849) / 0.023
=-3,591.30 %

Scope Fluidics Spolka Akcyjna's Gross Margin for the quarter that ended in Mar. 2026 is calculated as


Gross Margin % (Q: Mar. 2026 )=Gross Profit (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=-0.2 / 0.006
=(Revenue - Cost of Goods Sold) / Revenue
=(0.006 - 0.179) / 0.006
=-2,883.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of -2,883.33% mean?
Scope Fluidics Spolka Akcyjna (FRA:S84) has a Gross Margin % of -2,883.33% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. According to the industry distribution chart, Scope Fluidics Spolka Akcyjna ranks #194 out of 194 companies in the Medical Diagnostics & Research industry.
Is Scope Fluidics Spolka Akcyjna's Gross Margin % too high?
Scope Fluidics Spolka Akcyjna's current Gross Margin % is -2,883.33%. Based on the distribution chart, Scope Fluidics Spolka Akcyjna ranks #194 out of 194 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Scope Fluidics Spolka Akcyjna has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Scope Fluidics Spolka Akcyjna's Gross Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Scope Fluidics Spolka Akcyjna ranks #194 out of 194 companies for Gross Margin %. This places Scope Fluidics Spolka Akcyjna in the lower half of its industry. The industry median Gross Margin % is 50.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Diagnostics & Research company?
The median Gross Margin % among Medical Diagnostics & Research companies is 50.45, based on 194 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. For the Medical Diagnostics & Research industry, the median Gross Margin % is 50.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scope Fluidics Spolka Akcyjna's current Gross Margin % is -2,883.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scope Fluidics Spolka Akcyjna stock overvalued right now?
Scope Fluidics Spolka Akcyjna (FRA:S84) has a current Gross Margin % of -2,883.33%. The stock's GF Value™ is €26.71, compared to a current price of €23.50 — trading 12% below its estimated fair value. The current Gross Margin % is -2,883.33%. Scope Fluidics Spolka Akcyjna's overall GF Score™ is 45/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Scope Fluidics Spolka Akcyjna (FRA:S84), the current Gross Margin % is -2,883.33% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scope Fluidics Spolka Akcyjna (FRA:S84) Overvalued in 2026?

Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna stock appears to be undervalued. The current stock price of €23.50 is trading 12% below its estimated GF Value™ of €26.71.

Key valuation signals for FRA:S84:

  • Gross Margin %: -2,883.33%
  • GF Value™: €26.71 vs. price of €23.50 (12% below fair value)
  • GF Score™: 45/100 with 4 warning signs

No single metric tells the full story. See the FRA:S84 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Scope Fluidics Spolka Akcyjna Business Description

Other Exchanges SCP:Poland
Address Duchnicka 3, Build 16, Entrance A, Warsaw, POL, 01-796
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.
45GF Score

Get the complete analysis for FRA:S84

Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€23.50
Price
€26.71
GF Value